Brexanolone Lifting Outcomes Of Moms
Public ClinicalTrials.gov record NCT07822321. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral LPCN 1154A in Women With Postpartum Depression
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this research study is to test the study drug, LPCN 1154A, as a possible treatment for postpartum depression (PPD). The trial aims to determine: * If LPCN 1154A reduces depressive symptoms in subjects with severe PPD * How well LPCN 1154A is tolerated and what side effects it may cause
Study identification
- NCT ID
- NCT07822321
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 15 Years to 45 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2026
- Primary completion
- Jul 31, 2027
- Completion
- Aug 31, 2027
- Last update posted
- Sep 15, 2026
2026 – 2027
United States locations
- U.S. sites
- 16
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lipocine Investigational Site | Tucson | Arizona | 85715 | Recruiting |
| Lipocine Investigational Site | Canoga Park | California | 91304 | Recruiting |
| Lipocine Investigational Site | Walnut Creek | California | 94596 | Recruiting |
| Lipocine Investigational Site | Aurora | Colorado | 80045 | Recruiting |
| Lipocine Investigational Site | Decatur | Georgia | 30030 | Recruiting |
| Lipocine Investigational Site | Idaho Falls | Idaho | 83402 | Recruiting |
| Lipocine Investigational Site | Chicago | Illinois | 60641 | Recruiting |
| Lipocine Investigational Site | New Orleans | Louisiana | 70115 | Recruiting |
| Lipocine Investigational Site | Las Vegas | Nevada | 89119 | Recruiting |
| Lipocine Investigational Site | Princeton | New Jersey | 08540 | Recruiting |
| Lipocine Investigational Site | Manhattan | New York | 10036 | Recruiting |
| Lipocine Investigational Site | Chapel Hill | North Carolina | 27514 | Recruiting |
| Lipocine Investigational Site | Plano | Texas | 75093 | Recruiting |
| Lipocine Investigational Site | Richardson | Texas | 75080 | Recruiting |
| Lipocine Investigational Site | Clinton | Utah | 84105 | Recruiting |
| Lipocine Investigational Site | Orem | Utah | 84058 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07822321, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2026 · Synced Sep 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07822321 live on ClinicalTrials.gov.